Gilead Sciences, Inc.

Gilead Pharmasset LLC

Kyla Bjornson

John O Link

James G Taylor

Randall W Vivian

Jeff A Zablocki

Hyung-Jung Pyun

Sheila M Zipfel

Adam James Schrier

Kapil Kumar Karki

Jeromy J Cottell

Dustin S Siegel

Zheng-Yu Yang

Michael L Mitchell

Lianhong Xu

Darryl Kato

Barton W Phillips

Eda Y Canales

Chinh Viet Tran

Tetsuya Kobayashi

Teresa Alejandra Trejo Martin

Hongtao Liu

Michael Sangi

Ashley Anne Katana

Ruben Martinez

Kerim Babaoglu

Randall Halcomb

Hongyan Guo

Paul A Roethle

Ryan McFadden

Paul Hrvatin

James D Trenkle

Randall L Halcomb

James Taylor

Elizabeth M Bacon

Winston C Tse

Jianyu Sun

Steven S Bondy

Kirk L Stevens

Chien-hung Chou

Eric Lansdon

Yingmei Qi

Elizabeth Bacon

Ruchika Mishra

You-chul Choi

Dustin Siegel

Jeff Zablocki

Paul Roethle

Kapil K Karki

Compounds of Formula I are disclosed As well as pharmaceutically acceptable salts thereof. Methods of using said compounds and pharmaceutical compositions containing said compounds are also disclosed.

Inhibitors of hepatitis C virus

Compounds of Formula I are disclosed  As well as pharmaceutically acceptable salts thereof. Methods of using said compounds and pharmaceutical compositions containing said compounds are also disclosed.

Compounds of formula I: or pharmaceutically acceptable salts thereof, wherein the various substituents are defined herein, methods of using said compounds, and pharmaceutical compositions containing said compounds.

The invention provides compounds and salts thereof as d herein. The invention also provides pharmaceutical compositions comprising a compound disclosed herein, processes for preparing compounds disclosed herein, intermediates useful for preparing compounds disclosed herein and therapeutic methods for treating an HIV infection, treating the proliferation of the HIV virus, treating AIDS or delaying the onset of AIDS or ARC symptoms in a mammal using compounds disclosed herein.

2-(tert-butoxy)-2-(7-methylquinolin-6-yl) acetic acid derivatives for treating AIDS

The invention provides compounds of formula (I): or a salt thereof as described herein. The invention also provides pharmaceutical compositions comprising a compound of formula (I), processes for preparing compounds of formula (I), intermediates useful for preparing compounds of formula I and therapeutic methods for treating the proliferation of the HIV virus, treating AIDS or delaying the onset of AIDS or ARC symptoms in a mammal using compounds of formula (I). 

2-quinolinyl-acetic acid derivatives as HIV antiviral compounds

The invention provides compounds of formula (I): or a salt thereof as described herein. The invention also provides pharmaceutical compositions comprising a compound of formula I, processes for preparing compounds of formula (I), intermediates useful for preparing compounds of formula I and therapeutic methods for treating the proliferation of the HIV virus, treating AIDS or delaying the onset of AIDS or ARC symptoms in a mammal using compounds of formula (I). 

Naphth-2-ylacetic acid derivatives to treat AIDS

The invention is related to anti-viral compounds of formula (A) as defined in the claims, compositions containing such compounds, and therapeutic methods that include the administration of such compounds, as well to processes and intermediates useful for preparing such compounds. 

Heterocyclic flaviviridae virus inhibitors

Growing community of inventors

San Lorenzo, CA, United States of America

Kyla Bjornson